bevacizumab
roche
['ovarian', 'beva', 'bevacizumab']
benoit you on ovarian cancer who benefits from bevacizumab in the first-line setting - the asco post 
Oncologue medical spécialisé en essais cliniques de phase 1, CITOHL, phase 1 and 2 trials